Toggle Main Menu Toggle Search

Open Access padlockePrints

Do recipients of kidneys from donors treated with streptokinase develop anti-streptokinase antibodies?

Lookup NU author(s): Muhammed Gok, John Asher, Dr Brian Shenton, Professor Naeem Soomro, Bryon Jaques, Professor Derek Manas, David Talbot


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Streptokinase is used for preflush for non-heart-beating donors (NHBDs) in our center. The aim of this study was to evaluate whether the use of thrombolytic streptokinase results in the production of anti-streptokinase antibodies in the recipients after renal transplantation. Recipient sera taken prior to and at 1 and 6 months posttransplant were tested for the presence of antibodies to streptokinase using an enzyme-linked immunosorbent assay assay. No differences were detected between a group of 18 recipients who had kidneys from thrombolytic-treated NHBDs and a further group of 18 who received NHBD kidneys without such treatment. © 2005 by Elsevier Inc. All rights reserved.

Publication metadata

Author(s): Mi H, Gupta A, Gok MA, Asher JF, Shenton BK, Stamp S, Carter V, Del Rio Martin J, Soomro NA, Jaques BC, Manas DM, Talbot D

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 22nd Congress of the Scandinavian Transplantation Society

Year of Conference: 2005

Pages: 3272-3273

ISSN: 0041-1345

Publisher: Transplantation Proceedings, Elsevier


DOI: 10.1016/j.transproceed.2005.09.035

PubMed id: 16298569

Library holdings: Search Newcastle University Library for this item

Series Editor(s):

ISBN: 18732623